The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial.
Saved in:
| Title: | The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial. |
|---|---|
| Authors: | Armand P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Kim HT; Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Sainvil MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Lange PB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Giardino AA; Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA., Bachanova V; Department of Medical Oncology, University of Minnesota, Minneapolis, MN, USA., Devine SM; Department of Medicine, The Ohio State University Comprehensive Cancer Center Ohio State University, Columbus, OH, USA., Waller EK; Department of Hematology/Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA., Jagirdar N; Department of Hematology/Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA., Herrera AF; City of Hope Cancer Center, Duarte, CA, USA., Cutler C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Ho VT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Koreth J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Alyea EP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., McAfee SL; Bone Marrow Transplant Unit, Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA, USA., Soiffer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Chen YB; Bone Marrow Transplant Unit, Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA, USA., Antin JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. |
| Source: | British journal of haematology [Br J Haematol] 2016 Apr; Vol. 173 (1), pp. 96-104. Date of Electronic Publication: 2016 Jan 05. |
| Publication Type: | Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 26729448 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Armand+P%22">Armand P</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kim+HT%22">Kim HT</searchLink>; Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Sainvil+MM%22">Sainvil MM</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Lange+PB%22">Lange PB</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Giardino+AA%22">Giardino AA</searchLink>; Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Bachanova+V%22">Bachanova V</searchLink>; Department of Medical Oncology, University of Minnesota, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Devine+SM%22">Devine SM</searchLink>; Department of Medicine, The Ohio State University Comprehensive Cancer Center Ohio State University, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Waller+EK%22">Waller EK</searchLink>; Department of Hematology/Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Jagirdar+N%22">Jagirdar N</searchLink>; Department of Hematology/Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Herrera+AF%22">Herrera AF</searchLink>; City of Hope Cancer Center, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Cutler+C%22">Cutler C</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ho+VT%22">Ho VT</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Koreth+J%22">Koreth J</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Alyea+EP%22">Alyea EP</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22McAfee+SL%22">McAfee SL</searchLink>; Bone Marrow Transplant Unit, Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Soiffer+RJ%22">Soiffer RJ</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Chen+YB%22">Chen YB</searchLink>; Bone Marrow Transplant Unit, Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Antin+JH%22">Antin JH</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372544%22">British journal of haematology</searchLink> [Br J Haematol] 2016 Apr; Vol. 173 (1), pp. 96-104. <i>Date of Electronic Publication: </i>2016 Jan 05. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0372544 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2141 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071048%22">00071048 </searchLink><i>NLM ISO Abbreviation: </i>Br J Haematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26729448 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/bjh.13931 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 96 Titles: – TitleFull: The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Armand P – PersonEntity: Name: NameFull: Kim HT – PersonEntity: Name: NameFull: Sainvil MM – PersonEntity: Name: NameFull: Lange PB – PersonEntity: Name: NameFull: Giardino AA – PersonEntity: Name: NameFull: Bachanova V – PersonEntity: Name: NameFull: Devine SM – PersonEntity: Name: NameFull: Waller EK – PersonEntity: Name: NameFull: Jagirdar N – PersonEntity: Name: NameFull: Herrera AF – PersonEntity: Name: NameFull: Cutler C – PersonEntity: Name: NameFull: Ho VT – PersonEntity: Name: NameFull: Koreth J – PersonEntity: Name: NameFull: Alyea EP – PersonEntity: Name: NameFull: McAfee SL – PersonEntity: Name: NameFull: Soiffer RJ – PersonEntity: Name: NameFull: Chen YB – PersonEntity: Name: NameFull: Antin JH IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2016 Apr Type: published Y: 2016 Identifiers: – Type: issn-electronic Value: 1365-2141 Numbering: – Type: volume Value: 173 – Type: issue Value: 1 Titles: – TitleFull: British journal of haematology Type: main |
| ResultId | 1 |